Armor Pharma, in collaboration with its esteemed distribution partner MKT, proudly hosted its 1st technical seminar in Turkey, marking a significant milestone in the pharmaceutical industry. This event, held on November 25th, 2025, brought together key players and experts from the sector to explore critical topics such as direct compression lactose and Dry Powder Inhalers (DPIs) grades.
The seminar served as a dynamic platform for industry leaders to delve into the transformative potential of direct compression lactose. Known for its superior flow & compaction properties, those lactose grades are revolutionizing tablet manufacturing, offering enhanced efficiency and innovation in pharmaceutical production.
Additionally, the seminar spotlighted Dry Powder Inhalers (DPIs), which are at the forefront of respiratory treatment advancements. DPIs provide patients with a convenient and effective method of drug delivery, improving patient outcomes and expanding therapeutic possibilities.
Throughout the day, participants engaged in lively discussions, sharing insights and strategies to tackle current challenges and seize opportunities within the pharmaceutical sector. The event underscored the importance of collaboration, bringing together diverse perspectives and expertise to drive progress.
Armor Pharma extends its heartfelt gratitude to all attendees for their active participation and contributions. Special thanks to MKT for their exceptional support in organizing this successful event. Together, we are paving the way for excellence in the pharmaceutical industry.
Stay tuned for more updates and future initiatives from Armor Pharma!
